Safety and Convenience of Self-Administered Icatibant for the Treatment of Acute Hereditary Angioedema Attacks

被引:0
|
作者
Aberer, Werner [1 ]
Bygum, Anette [2 ]
Nair, Nitin [3 ]
Kivity, Shmuel [4 ]
机构
[1] Med Univ Graz, Graz, Austria
[2] Odense Univ Hosp, DK-5000 Odense, Denmark
[3] Shire Human Genet Therapies, Lexington, MA USA
[4] Tel Aviv Med Ctr & Sch Med, Tel Aviv, Israel
关键词
D O I
10.1016/j.jaci.2012.12.797
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:AB32 / AB32
页数:1
相关论文
共 50 条
  • [1] SAFETY, TOLERABILITY AND EFFICACY OF SELF-ADMINISTERED ICATIBANT FOR ACUTE ATTACKS OF HEREDITARY ANGIOEDEMA
    Aberer, W.
    Toubi, E.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2011, 107 (05) : A112 - A112
  • [2] PATIENTS' OPINIONS OF SELF-ADMINISTERED ICATIBANT FOR THE TREATMENT OF ACUTE HEREDITARY ANGIOEDEMA ATTACKS
    Toubi, E.
    Aberer, W.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2011, 107 (05) : A112 - A113
  • [3] Patients' preference for self-administered icatibant treatment of acute hereditary angioedema attacks
    Maurer, M.
    Malbran, A.
    Aberer, W.
    Wiednig, M.
    Reshef, A.
    Nair, N.
    Lachmann, A.
    Hoch, B.
    Bloom, B.
    Longhurst, H.
    Kivity, S.
    [J]. ALLERGY, 2011, 66 : 425 - 425
  • [4] Open-label, multicenter study of self-administered icatibant for attacks of hereditary angioedema
    Aberer, W.
    Maurer, M.
    Reshef, A.
    Longhurst, H.
    Kivity, S.
    Bygum, A.
    Caballero, T.
    Bloom, B.
    Nair, N.
    Malbran, A.
    [J]. ALLERGY, 2014, 69 (03) : 305 - 314
  • [5] Self-administered icatibant in a patient with hereditary angioedema type I
    Wiednig, M.
    [J]. ALLERGY, 2012, 67 : 352 - 352
  • [6] A study of the safety, tolerability and efficacy of self-administration of icatibant for acute attacks of hereditary angioedema
    Aberer, W.
    Wiednig, M.
    Reshef, A.
    Nair, N.
    Lachmann, A.
    Hoch, B.
    Bloom, B.
    Longhurst, H.
    Maurer, M.
    Kivity, S.
    Malbran, A.
    [J]. ALLERGY, 2011, 66 : 80 - 80
  • [7] Treatment of submucosal hereditary angioedema attacks with icatibant
    Csuka, D.
    Zotter, Z.
    Varga, L.
    Boeroecz, Z.
    Temesszentandrasi, G.
    Jakab, L.
    Karadi, I
    Farkas, H.
    [J]. ALLERGY, 2011, 66 : 426 - 427
  • [8] Icatibant: only in the treatment of hereditary angioedema attacks?
    Fernandes, M.
    Lourenco, T.
    Spinola Santos, A.
    Lopes, A.
    Cosme, J.
    Marcelino, J.
    Ferreira, R.
    Aguiar, R.
    Pestana, L.
    Almeida, P.
    Caiado, J.
    Duarte, F.
    Neto, M.
    Costa, A. C.
    Alonso, E.
    Branco Ferreira, M.
    Pedro, E.
    Barbosa, M.
    [J]. ALLERGY, 2017, 72 : 452 - 452
  • [9] Management of hereditary angioedema in Japan: Focus on icatibant for the treatment of acute attacks
    Hide, Michihiro
    Horiuchi, Takahiko
    Ohsawa, Isao
    Andresen, Irmgard
    Fukunaga, Atsushi
    [J]. ALLERGOLOGY INTERNATIONAL, 2021, 70 (01) : 45 - 54
  • [10] Clinical experience with Icatibant for treatment of acute attacks in patients with hereditary angioedema
    Oliveira Rodrigues do Valle, S.
    Tavares Franca, A.
    Afra Pires Levy, S.
    Malheiros, T.
    Mello, Y.
    Sarquis Serpa, F.
    Sevciovic Grumach, A.
    Albuquerque Campos, R.
    [J]. ALLERGY, 2012, 67 : 359 - 359